Radium-223 as an Additional Therapeutic Strategy in Highly Selected Patients With Metastatic Breast Cancer: A Case Report

Radium-223 is commonly used in metastatic prostate cancer, targeting specifically bone metastases. The use of radium-223 remains, however, poorly evaluated in metastatic breast cancer. We report a case of radium-223 treatment in a 59-year-old patient with bone-only metastatic disease that progressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Houssiau, Hélène, Duhoux, Francois P., François, Didier, Seront, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195502/
https://www.ncbi.nlm.nih.gov/pubmed/35712506
http://dx.doi.org/10.3389/fonc.2022.896301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195502/
https://www.ncbi.nlm.nih.gov/pubmed/35712506
http://dx.doi.org/10.3389/fonc.2022.896301

Ejemplares similares